Publications citing Assaypro: Human Apolipoprotein A-I (Apo A1) ELISA Kit... (82 results)
Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.Role of DJ-1 and Apo A1 as biomarkers in Parkinson's disease: an observational case-control study
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and...
Phytosterols and omega 3 supplementation exert novel regulatory effects on metabolic and inflammatory pathways: a proteomic study
- https://www.mdpi.com/2072-6643/9/6/599
- C Lambert, J Cubedo, T Padr�, J S�nchez-Hern�ndez...- Nutrients, 2017 - mdpi.com
- Cardiovascular disease (CVD) remains one of the major causes of death and disability worldwide. In addition to drug treatment, nutritional interventions or supplementations are...
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
High performance lipoprotein profiling for cardiovascular risk assessment
Intervenciones nutricionales en la prevenci�n cardiovascular y efectos de los factores de riesgo en el tejido adiposo
- https://diposit.ub.edu/dspace/handle/2445/148837
- C Lambert Goitia - 2019 - diposit.ub.edu
- [spa] Las enfermedades cardiovasculares son una de las principales causas de mortalidad y morbilidad a nivel mundial, apareciendo como consecuencia de la acumulaci�n de...
Dise�o de una herramienta auxiliar en el diagn�stico de c�ncer de pulm�n mediante la cuantificaci�n de prote�nas biomarcadoras utilizando redes neuronales...
Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
Nutritional interventions in cardiovascular prevention and effects of risk factors on adipose tissue
Leptin and Tumor necrosis factor alpha in breast
Serum Syndecan-1 and Apolipoprotein A1 in patients with chronic HCV infection
Diagnostic value of apolipoprotein A1 in neonatal sepsis
Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus
Role of DJ-1 and Apo A1 as biomarkers in Parkinson?s disease: an observational case-control study
Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection
Clinicopathological Analysis and Multipronged Quantitative Proteomics Reveal Oxidative Stress and Cytoskeletal Proteins as Possible Markers for Severe Vivax Malaria
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
Assessment of the relationship between markers of inflammation, adipokines and lipid metabolism parameters in overweight and obese individuals.
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols
Paraoxonase Responses to Exercise and Niacin Therapy in Men with Metabolic Syndrome
Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. Proteomics
Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity
A novel truncated form of Apolipoprotein A-I transported by dense LDL is increased in diabetic patients
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children
Glycoproteome of human apolipoprotein AI: N-and O-glycosylated forms are increased in patients with acute myocardial infarction
Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics
The relationship between serum amyloid A and apolipoprotein A-I in high-density lipoprotein isolated from patients with coronary heart disease
Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients
The Effects of Eight Weeks Interval Endurance Robe Training on Lymphocyte ABCA1 Protein Expression, Plasma Apolipoprotein A-I and HDL-cin Overweight and Obese Boy Adolescents
Artificial neural network-based serum biomarkers analysis improves sensitivity in the diagnosis of lung cancer
Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach
Eosinophil activation and novel mediators in the aspirin?induced nasal response in AERD
Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels
High Performance Lipoprotein Profiling for Cardiovascular Risk Assessment
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level
Identification of haptoglobin and apolipoprotein AI as biomarkers for high altitude pulmonary edema
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications
High-density lipoprotein associated factors apoA-I and serum amyloid A in Chinese non-diabetic patients with coronary heart disease
New sPLA 2 -reacted extracellular vesicles (SPLEVs) as a therapeutic modality for cytokine storm syndromes.
- No Link Provided
- Shunya Nakayama, Akane Kanamori, ..., Ai Kotani (2026). Science Advances. 2026 Jul 31
- .. lower than the minimum concentration of the standards were converted as the minimum concentration.. The assay for apolipoprotein A- 1 was also performed using ELISA, following the standard protocol for the AssayMax Human Apolipoprotein A- I ELISA Kit (Assaypro, USA).
A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection
- https://pubmed.ncbi.nlm.nih.gov/40899502/
- Kang N. Rebecca, Biondo John R., ..., Green Alexander A. (2025). bioRxiv. 2025 Mar 07
- PrePrint: Human Apolipoprotein A-I (ApoA1) AssayMax ELISA Kit (AssayPro) and Human Fibrinogen ELISA Kit - high sensitivity (AbCam) were purchased for ELISA tests.. Saliva samples were serially diluted and used for testing in triplicate according to the ..
A Rapid and Modular Nanobody Assay for Plug-and-Play Antigen Detection
- https://pubmed.ncbi.nlm.nih.gov/40899502/
- Kang N. Rebecca, Biondo John R., ..., Green Alexander A. (2025). bioRxiv. 2025 Mar 07
- PrePrint: Human Apolipoprotein A-I (ApoA1) AssayMax ELISA Kit (AssayPro) and Human Fibrinogen ELISA Kit - high sensitivity (AbCam) were purchased for ELISA tests.. Saliva samples were serially diluted and used for testing in triplicate according to the ..
Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study
- https://pubmed.ncbi.nlm.nih.gov/35591821/
- Aleksandra Cieluch, Aleksandra Uruska, ..., Dorota Zozulińska-Ziółkiewicz (2020). Archives of Medical Science. 2020 Oct 29
- ts: at the time of diagnosis (before administration of insulin) and at follow-up after 3 weeks, 6 months and 1 year of insulin treatment. The concentration of apo AI and apo AII was determined with AssayPro company tests using the immunoenzymatic method ELISA (enzyme-linked immunosorbent assay) using a TECAN-SUNRISE reader Is it time to change the goals of lipid management in type 1 diabetes mel
Self-reported Morisky Eight-item Medication Adherence Scale for Statins Concords with the Pill Count Method and Correlates with Serum Lipid Profile Parameters and Serum HMGCoA Reductase Levels
- https://pubmed.ncbi.nlm.nih.gov/37216136/
- Abhinav Grover, Mansi Oberoi, ..., Madhur Yadav (2020). Cureus. 2020 Jan 02
- LDL, TG, HDL, apolipoprotein A1, apolipoprotein B, and serum HMG CoA-R enzyme levels using the enzyme-linked immunosorbent assay (ELISA) method with the BMAssay (Beijing, China) HMGCoA-R kit and the AssayPro (St Charles, Missouri) apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB) ELISA kits. Statistical considerations The compliance data are presented as percentages for pill count and as mean
Serum apolipoprotein A1: a predictor and prognostic biomarker in acute ischemic stroke
- No Link Provided
- Mai A. Eldeeb, Amr S. Zaki (2019). The Egyptian Journal of Neurology, Psychia…. 2019 Dec 31
- .. at 3000× for 10 min, serum was obtained and stored at − 70 °C.. For the quantitative detection of ApoA1, the Human ApoA1 ELISA kit, which is provided by Assay pro LLC (number: EA5201-1), was used and the instructions were done according to the provided booklet.. The values of serum ApoA1 from each patient were noted and compared with values ..
Role of DJ-1 and Apo A1 as biomarkers in Parkinson’s disease: an observational case-control study
- No Link Provided
- Sahil Mehta, Ritu Shree, ..., Vivek Lal (2019). Annals of Movement Disorders. 2019 Jan 01
- .. the assay was 1.85 ng/mL with the coefficient of variation of less than 15%.. Estimation of Apo A1 by ELISA: Serum Apo A1 was measured in a similar way by Human Apo A1 ELISA kit Annals of Movement Disorders - Volume 2, Issue 3, September-December 2019 111 (Catalog No. EA5201-1, ASSAYPRO, St. Charles, Missouri).. It is an in vitro ELISA for the quantitative measurement of human Apo A1 ..
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function
- https://pubmed.ncbi.nlm.nih.gov/30240132/
- Michael A Tortorici, Danielle Duffy, ..., Denise D'Andrea (2018). Clinical Pharmacology in Drug Development. 2018 Sep 21
- er and K‐Assay Apo AI assay; Kamiya Biomedical Company, Tukwila, Washington) and enzyme‐linked immunosorbent assays (Molecular Devices VersaMaz plate reader and AssayMax Apolipoprotein A‐I ELISA kit; AssayPro, St. Charles, Missouri), respectively. PC was quantified enzymatically in plasma using phospholipase and choline oxidase forming hydrogen peroxide (Wako Phospholipids C assay; Wako Pure Chemic
Relationships of oxidized HDL with blood coagulation and fibrinolysis in patients with type 2 diabetes mellitus
- https://pubmed.ncbi.nlm.nih.gov/29247447/
- Shigeyuki Ebara, Mikio Marumo, ..., Ichiro Wakabayashi (2017). Journal of thrombosis and thrombolysis. 2017 Dec 15
- Abstract: Although oxidization of LDL is known to be a crucial step for atherosclerotic progression, the significance of oxidized HDL remains to be clarified. The purpose of this study was to determin…
Assessment of oxLDL, anti-oxLDL antibodies and lipoprotein-associated phospholipase A2 as cardiovascular risk markers in obese adolescents with and without T1DM
- No Link Provided
- Nesreen N. Omar, Mohamed H. EL Hefnawy, ..., Heba I. Hamed (2017). Bulletin of Faculty of Pharmacy, Cairo Uni…. 2017 Dec 01
- Serum apo AI concentration was measured using ELISA Kit ASSAY PRO (Catalog No EA5201-1) (AssayproLLC,St.Charles,MO63304), Serum apo B concentration was measured using commercially available ELISA Kit ASSAYPRO (Catalog No EA7001-1) (AssayproLLC,St.Charles,MO63304), Serum oxLDL concentration was measured using commercially available (ELISA) Kit Glory Science (Catalog No 90078) (Glory Science Co., USA), Serum oxLDL Ab concentration was measured using commercially available (ELISA) Kit OLAB (Catalog No BI ..
Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection
- https://pubmed.ncbi.nlm.nih.gov/28667326/
- Sandipan Ray, Sandip K Patel, ..., Sanjeeva Srivastava (2017). Scientific Reports. 2017 Jun 30
- , Serum amyloid A (SAA; P0DJI8), Hemopexin (HPX; P02790), Apolipoprotein E (Apo E; P02649), Haptoglobin (HP; P00738), and Apolipoprotein A1 (Apo A1; P02647) were quantified using AssayMax ELISA kits (AssayPro, USA) in serum samples from LPVM, MPVM and DF patients, and healthy controls following the manufacturer’s instructions. Serum abundances of these five proteins along with three other proteins
Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study
- https://pubmed.ncbi.nlm.nih.gov/28608804/
- Carmen Lambert, Judit Cubedo, ..., Lina Badimon (2017). Nutrients. 2017 Jun 13
- .. kit in the whole cohort ( N = 32; ).. The detection limit of the assays were: 1.5 ng/mL for Apo E (ELH-Apo E; Human Apo E ELISA Kit; RayBiotech, Norcross, GA, USA); 0.7 µg/mL for Apo A–I (EA5201-1; Human Apo A–I ELISA Kit; AssayPro, St. Charles, MO, USA); and 0.27 ng/mL for LCAT (RD191122200R; LCAT ELISA Kit; BioVendor, Brno-Řečkovice a MokráHora, Czech Republic).
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
- https://pubmed.ncbi.nlm.nih.gov/28228309/
- Abhinav Grover, Harmeet Singh Rehan, ..., Madhur Yadav (2017). Indian Heart Journal. 2017 Jan 01
- LDL-C, HDL-C, TG, ApoA1 and ApoB) and serum HMGCoA-R enzyme levels. TC, TG, LDL-C and HDL-C were measured by enzymatic assay calorimeter of Randox Reagents. BMAssay HMGCoA-R (kit number – 26215,96T), AssayPro ApoA1 (kit number – 02681524) and AssayPro ApoB ELISA kit (kit number – 06982406) were used to measure HMGCoA-R levels. The minimum detectable levels of HMGCoA-R, ApoA1, ApoB were 0.06 ng/mL,
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma
- https://pubmed.ncbi.nlm.nih.gov/27495108/
- Chao Lin, Wen-Chuan Wu, ..., Da-Yong Jin (2016). Medicine. 2016 Aug 01
- ELISA was conducted in some marker candidates using human APOA-I ELISA kit (Assay Pro) and TF ELISA kit (Alpco).. Their optical density wasmeasured at 450nm using amicroplate reader (iMark Microplate Reader S/N 10288).Their ..
The effects of Zanthoxylum bungeanum extract on lipid metabolism induced by sterols.
- https://pubmed.ncbi.nlm.nih.gov/25837921/
- Tingting Wu, Liangjie Zhong, ..., Yizhun Zhu (2016). Journal of pharmacological sciences. 2016 Apr 05
- .. levels in the serum samples were purchased from NanJing JianCheng Bioengineering Institute (Nanjing, China).. Human apoB and apoA1 ELISA kit were purchased from Assaypro (MO, USA) and Shanghai Hufeng Biotechnology Company (Shanghai, China) respectively.. BCA protein assay kit was purchased from Shanghai Biocolor BioScience & Technology Company (Shanghai, ..
A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients 1A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients 1 [S]
- No Link Provided
- Judit Cubedo, Teresa Padró, ..., Lina Badimon (2015). Journal of Lipid Research. 2015 Sep 17
- ApoA-I serum concentration in DM (N = 55) and nonDM (N = 59) patients was determined by competitive sandwich enzyme-linked immunosorbent assay (AssayPro) using immobilized polyclonal antibodies, as described by the providers. The detection limit of the assay was 1.2 μg/ml and the intra-assay and inter-assay coefficients of variation were 4.6 and 7.3%, respectively.
Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA [S]
- https://pubmed.ncbi.nlm.nih.gov/25561459/
- Ruud S Kootte, Loek P Smits, ..., ErikS Stroes (2015). Journal of Lipid Research. 2015 Mar 01
- The assays of total plasma and unesterified cholesterol were performed on the automated biochemical automator Pentra 400 (Horiba ABX Diagnostics, Montpellier, France) using cholesterol-oxidase enzymatic reaction. The assay of apoA-I was performed using a commercial ELISA kit (Assay Pro, Corona, CA). Intra-assay coefficient of variance was 4.8% with an inter-assay coefficient of variance of 7.21%.
Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas
- https://pubmed.ncbi.nlm.nih.gov/25413884/
- Samridhi Sharma, Sandipan Ray, ..., Sanjeeva Srivastava (2015). Proteomics. 2015 Jan 01
- Abstract: Meningiomas (MGs) are frequent tumors of the CNS originating from the meningeal layers of the spinal cord and the brain. In this study, comparative tissue proteomic analysis of low and high …
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
- https://pubmed.ncbi.nlm.nih.gov/25413266/
- Samridhi Sharma, Sandipan Ray, ..., Sanjeeva Srivastava (2014). Scientific Reports. 2014 Nov 21
- ferent grades of meningiomas; grade I (n = 14), grade II (n = 5) and grade III (n = 1) and healthy controls (n = 45) were measured using AssayMax ELISA kits following the manufacturer's instructions (AssayPro, USA). Optical densities were measured at 450 nm and 570 nm using a SpectraMax M2e (Molecular Devices, USA). Statistical significance of differential expression of the serum proteins was anal
CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice.
- https://pubmed.ncbi.nlm.nih.gov/24401224/
- Claudine Tardy, Marine Goffinet, ..., Rudi Baron (2014). Atherosclerosis. 2014 Sep 16
- In the study, the Human Apolipoprotein A I Apo A1 AssayMax ELISA Kit from Assaypro was utilized to measure plasma human apoA-I concentration, which was crucial for evaluating the effec…
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
- https://pubmed.ncbi.nlm.nih.gov/25180827/
- James Kyle Taylor, Eric P. Plaisance, ..., Peter W. Grandjean (2014). Redox Report. 2014 Sep 02
- PON1 concentration, Apo A1, oLDL, and myeloperoxidase (MPO) were determined using an enzymelinked immunosorbent assay: (Catalog# E0243HU, USCN Life Sciences Inc., Wuhan, China; Catalog# EA5201-1, AssayPro LLC., St Charles, MO, USA; Catalog# BI20042, ALPCO Diagnostics, Salem, NH, Redox Report 2015 VOL.. 20 NO. 1 43 USA; and Catalog# K6631A, ALPCO Diagnostics).20 ..
Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction
- https://pubmed.ncbi.nlm.nih.gov/24709669/
- Judit Cubedo, Teresa Padró, Lina Badimon (2014). Translational Research. 2014 Sep 01
- Abstract: High-density lipoprotein (HDL) functionality, which is closely associated with its composition and transport capabilities, determines its role in atheroprotection. During acute phase process…
Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children
- https://pubmed.ncbi.nlm.nih.gov/24949022/
- Gabriel Á Martos-Moreno, Lucila Sackmann-Sala, ..., John J Kopchick (2014). International Journal of Pediatric Endocri…. 2014 Jun 10
- Abstract: Early diagnosis of initial metabolic derangements in young obese children could influence their management; however, this impairment is frequently not overt, but subtle and undetectable by r…
Genetic Polymorphisms in the APOA1 Gene and their Relationship with Serum HDL Cholesterol Levels
- https://pubmed.ncbi.nlm.nih.gov/24081495/
- Fatemeh Bandarian, Mehdi Hedayati, ..., Fereidoun Azizi (2013). Lipids. 2013 Oct 01
- Abstract: Low high density lipoprotein cholesterol (HDL-C) is a known risk factor of coronary artery disease. Apolipoprotein A1 (APOA1) is the most abundant component of HDL-C. This study aimed at ide…
Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics
- https://pubmed.ncbi.nlm.nih.gov/23916703/
- Qiong Wen, Li Zhang, ..., Xue-Qing Yu (2013). Biochemical and biophysical research commu…. 2013 Aug 01
- In this study, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit from Assaypro was integral in validating the changes in levels of Apolipoprotein A1 in peritoneal dialysis efflu…
Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD
- https://pubmed.ncbi.nlm.nih.gov/23786280/
- G.-S. Choi, J.-H. Kim, ..., H.-S. Park (2013). Clinical Experimental Allergy. 2013 Jun 21
- In the study, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit from Assaypro was employed to measure apolipoprotein A1 levels in nasal lavage fluid, which was essential for elu…
The Effects of Rope Training on Lymphocyte ABCA1 Expression, Plasma ApoA-I and HDL-c in Boy Adolescents
- https://pubmed.ncbi.nlm.nih.gov/23825977/
- Bahloul Ghorbanian, Aliasghar Ravassi, ..., Mahdi Hedayati (2013). International Journal of Endocrinology and…. 2013 Apr 01
- In this study, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit from Assaypro was essential for measuring plasma ApoA-I levels, allowing researchers to investigate the effects …
Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach *
- https://pubmed.ncbi.nlm.nih.gov/23059768/
- Shannon K Flood-Nichols, Deborah Tinnemore, ..., Danielle L Ippolito (2013). Molecular & cellular proteomics : MCP. 2013 Jan 25
- po C-III, Apo A-I, and Apo A-II were used in ELISA assays to probe n = 5 patient specimens ( n = 2 technical replicates per patient) at 2–4 gestational ages according to manufacturer instructions (AssayPro, St. Charles, MO). Apolipoprotein concentration was determined by measuring optical densities at 450 nm absorption and interpolating to a standard calibration curve by microplate spectrophotom
Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients
- https://pubmed.ncbi.nlm.nih.gov/23739642/
- Maki Miyamoto-Sasaki, Tomoyuki Yasuda, ..., Ken-ichi Hirata (2013). Journal of atherosclerosis and thrombosis. 2013 Jan 01
- All values are presented as the mean±SD. Comparisons between the parameters of pre- and postpitavastatin treatment were made with paired Stu- measured using a commercially available ELISA kit (ASSAYPRO, MO, USA). The lipoprotein profiles were determined using HPLC (LipoSEARCH®) at Skylight Biotech, Inc. (Akita, Japan), according to the specified procedure21). The levels of HDL-phospholipids, total
Artificial Neural Network-Based Serum Biomarkers Analysis Improves Sensitivity in the Diagnosis of Lung Cancer
- No Link Provided
- J. M. Flores, E. Herrera, ..., M. Martínez-Velázquez (2013). IFMBE Proceedings. 2013 Jan 01
- In the study, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit from Assaypro was employed to measure Apo A1 levels in serum samples, which played a significant role in the anal…
Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis
- https://pubmed.ncbi.nlm.nih.gov/22267330/
- Christina Charles-Schoeman, Yuen Yin Lee, ..., Srinivasa T Reddy (2012). Annals of the Rheumatic Diseases. 2012 Jul 23
- ApoA-I levels were determined by direct ELISA according to the manufacturer’s protocol (AssayPro, St Charles, Missouri, USA). In brief, 25 µl of standard or sample were added to a 96-well plate coated with a polyclonal antibody against human Apo A-I. 25 µl of biotinlylated ApoA-I was added to each well and the plate was incubated for 2 h, washed and 50 µl of streptavidin-peroxidase conjugate was a
Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.
- https://pubmed.ncbi.nlm.nih.gov/21755356/
- Yasmin Ahmad, Dhananjay Shukla, ..., Kalpana Bhargava (2011). Functional & integrative genomics. 2011 Dec 01
- In the investigation of high altitude pulmonary edema (HAPE), the Human Apolipoprotein A I Apo A1 AssayMax ELISA Kit from Assaypro was employed to validate the findings from the proteo…
Anti-ATP Synthase Autoantibodies from Patients with Alzheimer's Disease Reduce Extracellular HDL Level
- https://pubmed.ncbi.nlm.nih.gov/21677380/
- Davide Vacirca, Cristiana Barbati, ..., Elena Ortona (2011). Journal of Alzheimer's Disease. 2011 Sep 19
- In the study on Alzheimer's disease, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit from Assaypro was instrumental for measuring apolipoprotein A-I levels in patient samples,…
Plasma profiles in active systemic juvenile idiopathic arthritis: biomarkers and biological implications
- https://pubmed.ncbi.nlm.nih.gov/21136595/
- Xuefeng B Ling, Jane L Park, ..., Elizabeth D Mellins (2010). Proteomics. 2010 Dec 05
- In the study, the Human Apolipoprotein A-I (Apo A1) AssayMax ELISA Kit facilitated the measurement of critical proteins integral to identifying and validating SJIA flare signatures. By…